Adagio Therapeutics Inc. (NASDAQ:ADGI) saw a downside of -37.57% on Friday at $26.37 after subtracting -$15.87. The 5-day average trading volume is 531,071 shares of the company’s common stock. It has gained $46.15 in the past week. An average of 698,058 shares of the company has been traded in the last 20 days.
ADGI’s 1-month performance is 24.82% or -$8.48 on its low of $23.83 reached on 10/01/21. The company’s shares have touched a 52-week low of $20.50 and high of $59.50. YTD, ADGI has achieved 102.30%. However, the current price is down -55.68%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Adagio Therapeutics Inc. (ADGI) has a trailing price-to-earnings (P/E) ratio of 33.74 for the broader industry and 32.22 for the sector, meaning that investors are optimistic about the stock’s future prospects. ADGI stock has a beta of 0.00. Adagio Therapeutics Inc.’s quick ratio for the period ended June 29 was 10.50, with the current ratio over the same period at 10.50 meaning that ADGI stock is able to fulfill its debt obligations.
For the quarterly period ending June 29 this year, Analysts expected ADGI to announce -$0.8 per share in earnings in its latest quarter, but it posted -$0.18, representing a 77.50% surprise. ADGI stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 45.26 million. Shareholders hold equity totaling $8.23 million
Let’s look briefly at Adagio Therapeutics Inc. (ADGI) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 30 September was 27.89% to suggest the stock is trending oversold, with historical volatility in this time period at 261.68%.
The stock’s 5-day moving average is $38.54, reflecting a -42.20% or -$18.45 change from its current price. ADGI is currently trading -29.49% above its 20-day SMA.
Stochastic %K and %D was 12.12% and 12.97% and the average true range (ATR) pointed at 6.86. The RSI (14) points at 36.03%, while the 14-day stochastic is at 4.04% with the period’s ATR at 6.21. The stock’s 9-day MACD Oscillator is pointing at -5.75 and -9.29 on the 14-day charts.
In the most recent analyst report for Adagio Therapeutics Inc. (NASDAQ: ADGI), Stifel launched coverage with a Buy rating. Analysts offering their rating for ADGI stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate ADGI as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is ADGI’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $33.00 and a high of $60.00, with their median price target at $56.50. Looking at these predictions, the average price target given by analysts is for Adagio Therapeutics Inc. (ADGI) stock is $51.50.